GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that data from two drug candidates in its clinical pipeline, GMI-1271 and rivipansel (formerly known as GMI-1070), will be featured during four oral presentations and two poster sessions at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is being held December 6-9, 2014, at the Moscone Center in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
